These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate. Buchanan MR; Butt RW; Hirsh J; Markham BA; Nazir DJ Prostaglandins Leukot Med; 1986 Feb; 21(2):157-68. PubMed ID: 3083434 [TBL] [Abstract][Full Text] [Related]
25. What regulates placental steroidogenesis in 90-day pregnant ewes? Weems YS; Kim L; Tsuda V; Yin C; Weems CW Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888 [TBL] [Abstract][Full Text] [Related]
26. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
29. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets. Lewis GP; Watts IS Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211 [TBL] [Abstract][Full Text] [Related]
30. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855 [TBL] [Abstract][Full Text] [Related]
31. Simultaneously increased TxA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Ungvari Z; Sarkadi-Nagy E; Bagi Z; Szollár L; Koller A Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1203-8. PubMed ID: 10807734 [TBL] [Abstract][Full Text] [Related]
32. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Hill E; Fitzpatrick F; Murphy RC Br J Pharmacol; 1992 Jun; 106(2):267-74. PubMed ID: 1327375 [TBL] [Abstract][Full Text] [Related]
33. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of the biosynthesis of prostanoids and hydroxyeicosatetraenoic acids in human whole blood and platelets by targeted chiral lipidomics analysis. Tacconelli S; Fullone R; Dovizio M; Pizzicoli G; Marschler S; Bruno A; Zucchelli M; Contursi A; Ballerini P; Patrignani P Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158804. PubMed ID: 32853794 [TBL] [Abstract][Full Text] [Related]
35. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809 [TBL] [Abstract][Full Text] [Related]
36. Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Khasawneh FT; Huang JS; Mir F; Srinivasan S; Tiruppathi C; Le Breton GC Biochem Pharmacol; 2008 Jun; 75(12):2301-15. PubMed ID: 18455148 [TBL] [Abstract][Full Text] [Related]
37. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
38. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. Escalante B; Sessa WC; Falck JR; Yadagiri P; Schwartzman ML J Pharmacol Exp Ther; 1989 Jan; 248(1):229-32. PubMed ID: 2492340 [TBL] [Abstract][Full Text] [Related]
39. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Johnson GJ; Leis LA; Francis GS Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784 [TBL] [Abstract][Full Text] [Related]